Chronic exposure to interferon (IFN)-alpha, an innate immune cytokine, produces high rates of behavioral disturbances, including depression and fatigue. These effects may be mediated by the actions of IFNalpha on dopamine (DA) metabolism in the basal ganglia. Diminished conversion of phenylalanine (Phen) to tyrosine (Tyr), the primary amino acid precursor of DA, has been associated with inflammation, and may reflect decreased activity of the enzyme phenylalanine-hydroxylase (PAH). This study investigated the peripheral Phen/Tyr ratio in relation to cerebrospinal fluid (CSF) concentrations of DA and its metabolites in subjects treated with IFN-alpha plus ribavirin for hepatitis C and controls awaiting IFN-alpha therapy. Plasma Phen/Tyr ratios were significantly increased in IFN-alpha-treated subjects (n = 25) compared to controls (n = 9), and were negatively correlated with CSF DA (r = À0.59, df = 15, p < 0.05) and its metabolite, homovanillic acid (r = À0.67, df = 15, p < 0.01), and positively correlated with fatigue (r = 0.44, df = 23, p < .05) in IFN-alpha-treated patients but not controls. Given the role of tetrahydrobiopterin (BH4) in the PAH conversion of Phen to Tyr, CSF concentrations of BH4 and its inactive oxidized form, dihydrobiopterin (BH2), were examined along with CSF interleukin (IL)-6 in a subset of patients. BH2 concentrations were significantly increased in IFN-alpha-treated patients (n = 12) compared to controls (n = 7), and decreased CSF BH4 concentrations correlated with increased CSF IL-6 (r = À0.57, df = 12, p < 0.05). These results indicate that IFN-alpha is associated with decreased peripheral conversion of Phen to Tyr, which in turn is associated with reduced DA in the brain as well as fatigue. These alterations may be related to oxidation of BH4 secondary to IFN-alpha-induced activation of a CNS inflammatory response.
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Introduction
Activation of the innate immune system has been shown to affect behavior through changes in neurocircuitry and neurotransmitter systems in the brain, mediated in part by effects of inflammatory cytokines on monoamine neurotransmission (Dantzer et al., 2008; Haroon et al., 2012; Miller et al., 2009 ). Recent evidence indicates that the basal ganglia and dopamine (DA) may be primary targets of inflammatory cytokines leading to cytokine-induced behavioral changes (Capuron et al., 2007, in press; Haroon et al., 2012; Liu and Hong, 2003; Theodore et al., 2006 Theodore et al., , 2008 . The basal ganglia are key subcortical structures regulating motivation and motor activity (Grace, 2002) , and cytokine effects on basal ganglia DA may contribute to the development of depression and fatigue, as well as psychomotor disturbances, in both medically ill and medically healthy subjects.
Numerous studies have reported elevated inflammatory cytokines in depressed individuals (Maes, 1999; Sluzewska, 1999) , and patients exposed to increased inflammation during chronic illness experience significantly higher rates of depression and fatigue than the general population (Yirmiya, 2000; Yirmiya et al., 2000 Yirmiya et al., , 1999 . Evidence that inflammatory cytokines can cause behavioral alterations exists in numerous reports of the neuropsychiatric symptoms induced by chronic administration of the inflammatory cytokine, interferon (IFN)-alpha, used to treat certain cancers and viral infections. Indeed, IFN-alpha produces an array of behavioral disturbances, many of which are consistent with decreases in basal ganglia DA function including anhedonia, fatigue, and psychomotor
